Welcome to our dedicated page for GoodRx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.
GoodRx Holdings, Inc. (Symbol: GDRX) is a leading consumer-focused digital healthcare platform committed to reducing the cost of healthcare in the United States. The company operates a price comparison platform that provides consumers with current, geographically relevant pricing for prescription medications. GoodRx gathers prices from multiple sources, offering powerful savings tips, valuable discounts, and negotiable price codes for prescriptions at virtually every pharmacy across the US.
GoodRx serves millions of Americans each month, including thousands of physicians who use the platform to help their patients. To date, the company has saved users over $3 billion on their prescription drug costs. Despite this success, GoodRx continues to work toward making prescriptions affordable for all Americans.
The company's core revenue stream comes from pharmacy benefit managers (PBMs), who manage formularies and prescription transactions. GoodRx also offers additional healthcare products and services such as pharma manufacturer solutions, subscription plans, and telehealth services. Their platform extends beyond individual consumers to include solutions for health plans, payors, and PBMs through an easy-to-use website and mobile app experience known as GoodRx for Benefits.
As GoodRx continues to innovate and expand its offerings, it remains dedicated to its mission of lowering healthcare costs and making essential medications accessible to everyone in the US. Stay updated with the latest news and developments from GoodRx to see how they are transforming the healthcare landscape.
GoodRx Holdings (GDRX) announced its participation in three upcoming virtual investor conferences. The events include the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 11:00 a.m. PT, the Citi 2021 Global Technology Virtual Conference on September 14 at 9:10 a.m. PT, and the Goldman Sachs 30th Annual Communacopia Conference on September 22 at 11:55 a.m. PT. Live webcasts and archived recordings will be accessible on their Investor Relations website. GoodRx, a leader in healthcare savings, has helped Americans save over $30 billion since 2011.
GoodRx Holdings (GDRX) announced its second quarter 2021 financial results on August 12, with a conference call scheduled to discuss the outcomes and future outlook. The company claims to have saved Americans over $30 billion since 2011, providing affordable healthcare services like telehealth and lab tests. GoodRx emphasizes its role as America’s leading resource for healthcare savings.
GoodRx, Inc. (Nasdaq: GDRX) and Boehringer Ingelheim have initiated a partnership to enhance access to copay programs for diabetes and COPD medications on the GoodRx platform. This collaboration aims to provide approximately $15 million in annual savings for patients in need of life-enhancing drugs. Diabetes impacts over 10% of the U.S. population, with medical costs considerably higher for affected individuals. With more patients facing increased financial burdens due to insurance changes, this initiative seeks to alleviate some of the cost barriers.
GoodRx (NASDAQ: GDRX) has formed a partnership with Surescripts to integrate drug discount pricing into Surescripts' Real-Time Prescription Benefit system. This collaboration aims to enhance prescription price transparency, particularly for uninsured patients and those lacking price information from their health plans. The initiative could lead to significant savings—up to 80%—on prescriptions, fostering better patient decision-making at the point of care. This effort aligns with GoodRx's mission to improve healthcare affordability for Americans.
GoodRx (NASDAQ: GDRX) recently published a consumer survey revealing its positive impact on pharmacy retailers. Key findings show that GoodRx enhances medication affordability, with 81% of users able to afford all prescriptions after using the service, compared to only 23% beforehand. Additionally, nearly 80% of users reported buying other items while picking up prescriptions, averaging $40 in extra purchases. The survey also indicated that 85% of participants were more likely to return to their pharmacy due to their positive experience with GoodRx, highlighting its role in boosting foot traffic and customer loyalty.
GoodRx Holdings (Nasdaq: GDRX) plans to release its Q2 2021 financial results on August 12, 2021, before U.S. markets open. A conference call will follow at 5:00 a.m. PT (8:00 a.m. ET) to discuss the results and business outlook. A shareholder letter and detailed financial results will be available on their investor relations website. GoodRx is recognized as America's leading resource for healthcare savings, having helped Americans save over $30 billion since 2011 and is the most downloaded medical app for the last three years.
GoodRx (NASDAQ: GDRX) has partnered with DoorDash (NYSE: DASH) to offer discounted access to its GoodRx Gold subscription program for DoorDash drivers, known as 'Dashers.' This partnership allows Dashers to save up to 90% on over 1,000 medications and provides online doctor visit discounts along with free mail delivery for prescriptions. GoodRx Gold can save individuals an average of $2,600 annually when filling 2 prescriptions monthly. This initiative aims to enhance healthcare access for the growing freelance workforce in the U.S., which comprises 35% of all workers.
GoodRx (NASDAQ: GDRX) released a report detailing its positive impact on American healthcare, showcasing significant savings for patients. In 2020, GoodRx users saved an average of 79% on medications, equating to around $30 billion in total savings. The platform has improved medication adherence, contributing to the prevention of over 1,000 hospitalizations and saving nearly 500 lives. Additionally, over 20% of Americans reported struggling with basic necessities due to medication costs, highlighting the importance of GoodRx in alleviating financial burdens.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its financial results for the first quarter of 2021, showcasing its role as a leader in healthcare savings in the U.S. The company has facilitated over $30 billion in savings since 2011. A conference call to discuss these results and the business outlook is scheduled for May 13, 2021, at 2:00 PM PT. GoodRx emphasizes its services, including affordable prescriptions, telehealth, and lab tests, making it the #1 most downloaded medical app for the last three years.
FAQ
What is the current stock price of GoodRx Holdings (GDRX)?
What is the market cap of GoodRx Holdings (GDRX)?
What does GoodRx Holdings, Inc. do?
How does GoodRx save money on prescriptions?
Who benefits from using GoodRx?
How much has GoodRx saved Americans so far?
What additional services does GoodRx offer?
How does GoodRx generate revenue?
What is GoodRx for Benefits?
Is GoodRx available as a mobile app?
Why should I use GoodRx if I already have insurance?